Patterns of urinary excretion of steroids in Cushing's syndrome.
D015065:17-Hydroxycorticosteroids; D015068:17-Ketosteroids; D000310:Adrenal Gland Neoplasms / Q000378:metabolism*; D000308:Adrenocortical Hyperfunction / Q000378:metabolism*; D000324:Adrenocorticotropic Hormone / Q000494:pharmacology; D000328:Adult; D000368:Aged; D003480:Cushing Syndrome / Q000175:diagnosis*; D003907:Dexamethasone / Q000494:pharmacology; D005260:Female; D006801:Humans; D008297:Male; D008797:Metyrapone / Q000494:pharmacology; D008875:Middle Aged; D010901:Pituitary Function Tests; D010912:Pituitary-Adrenal Function Tests; D011276:Pregnanediol / Q000378:metabolism*; D011279:Pregnanetriol / Q000378:metabolism*; D014556:Urine
D015065:17-Hydroxycorticosteroids; D015068:17-Ketosteroids; D011279:Pregnanetriol; D003907:Dexamethasone; D000324:Adrenocorticotropic Hormone; D011276:Pregnanediol; D008797:Metyrapone